119 related articles for article (PubMed ID: 18415803)
1. Variant CD44 expression by human fibroblasts.
Rajarajan A; Bloor BK; Desai H; Stokes A; Odell EW
Biomarkers; 2008 May; 13(3):307-18. PubMed ID: 18415803
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis.
Kitahori Y; Cho M; Konishi N; Ohshima M; Matsui E; Ohnishi T; Imai S; Hiasa Y
Int J Oncol; 1998 Sep; 13(3):505-11. PubMed ID: 9683785
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CD44 splicing patterns in normal keratinocytes, dysplastic and squamous carcinoma cell lines.
Bloor BK; Jelvagharan M; White KN; Odell EW
Int J Oncol; 2001 May; 18(5):1053-9. PubMed ID: 11295056
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
Liu NP; Roberts WL; Hale LP; Levesque MC; Patel DD; Lu CL; Jaffe GJ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2027-37. PubMed ID: 9331266
[TBL] [Abstract][Full Text] [Related]
6. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
[TBL] [Abstract][Full Text] [Related]
7. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW
Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634
[TBL] [Abstract][Full Text] [Related]
8. Antisense inhibition of CD44 tailless splice variant in human articular chondrocytes promotes hyaluronan internalization.
Jiang H; Knudson CB; Knudson W
Arthritis Rheum; 2001 Nov; 44(11):2599-610. PubMed ID: 11710716
[TBL] [Abstract][Full Text] [Related]
9. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
Yu Q; Toole BP
J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806
[TBL] [Abstract][Full Text] [Related]
10. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of the CD44 variant sharing exon v10 in renal cancer.
Kan M; Aki M; Akiyama K; Naruo S; Kanayama H; Kagawa S
Jpn J Cancer Res; 1995 Sep; 86(9):847-53. PubMed ID: 7591962
[TBL] [Abstract][Full Text] [Related]
12. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
[TBL] [Abstract][Full Text] [Related]
13. CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.
Rajarajan A; Stokes A; Bloor BK; Ceder R; Desai H; Grafström RC; Odell EW
PLoS One; 2012; 7(1):e28776. PubMed ID: 22242150
[TBL] [Abstract][Full Text] [Related]
14. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
[TBL] [Abstract][Full Text] [Related]
15. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors.
Saegusa M; Okayasu I
Jpn J Cancer Res; 1998 Mar; 89(3):291-8. PubMed ID: 9600123
[TBL] [Abstract][Full Text] [Related]
17. CD44 isoform expression in periodontal tissues: cell-type specific regulation of alternative splicing.
Hirano F; Hirano H; Hino E; Takayama S; Saito K; Kusumoto Y; Shimabukuro Y; Murakami S; Okada H
J Periodontal Res; 1997 Nov; 32(8):634-45. PubMed ID: 9409458
[TBL] [Abstract][Full Text] [Related]
18. Expression of variant CD44 epitopes in human astrocytic brain tumors.
Eibl RH; Pietsch T; Moll J; Skroch-Angel P; Heider KH; von Ammon K; Wiestler OD; Ponta H; Kleihues P; Herrlich P
J Neurooncol; 1995 Dec; 26(3):165-70. PubMed ID: 8750182
[TBL] [Abstract][Full Text] [Related]
19. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
[TBL] [Abstract][Full Text] [Related]
20. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
Bennett KL; Jackson DG; Simon JC; Tanczos E; Peach R; Modrell B; Stamenkovic I; Plowman G; Aruffo A
J Cell Biol; 1995 Feb; 128(4):687-98. PubMed ID: 7532176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
